Skip to content

Tilray Brands, Inc. TLRY Cash & Equivalents

Cash & Equivalents at other companies

Boston Beer logo
Boston BeerSAM
$164.12M+7.7%
Cronos Group logo
Cronos GroupCRON
$821.86M+3.0%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$24.47M-46.6%
PBH
Prestige Consumer HealthcarePBH
$63.87M-34.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$261.46M+43.5%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$1.31B+13.4%

Other financials

Income statement

See full
Revenue$206.7M+11.3%
Gross profit$55.0M+5.7%
Operating income-$26.4M+96.5%
Net income-$26.6M+96.6%
EPS (diluted)-$0.24+97.2%

Balance sheet

See full
Total debt$211.4M-6.9%
Total equity$1.6B-42.9%
Total assets$2.1B-39.0%

Cash flow

See full
Operating cash flow-$21.9M-281%
CapEx$6.3M-34.8%
Free cash flow-$19.1M

Valuation

See full
Market cap$538.85M+47.3%
Enterprise value$545.59M+46.8%
P/S0.6×+0.2×

Profitability

See full
Gross margin30.9%+2.9pp
Operating margin-103.5%-198pp
Net margin-156.1%+89.5pp
FCF margin-15.5%

Returns & leverage

See full
Return on equity-62.5%-1,636pp
Debt / equity0.1×+0.1×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Tilray Brands, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Tilray Brands, Inc.’s 10-Q, filed April 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tilray Brands, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tilray Brands, Inc.'s cash & equivalents?
Tilray Brands, Inc. (TLRY) reported cash & equivalents of $204.62M in Q4 2025.
How has Tilray Brands, Inc.'s cash & equivalents changed year-over-year?
Tilray Brands, Inc.'s cash & equivalents increased by 2.3% year-over-year, from $199.96M to $204.62M.
What is the long-term trend for Tilray Brands, Inc.'s cash & equivalents?
Over 4 years (2021 to 2025), Tilray Brands, Inc.'s cash & equivalents has grown at a -17.9% compound annual growth rate (CAGR), from $488.47M to $221.67M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.